ArticleFrontiers in neuroscience2025
Periosteal pressure sensitivity of the chest bone as a measure for autonomic function in ischemic heart disease.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: In 177 patients with ischemic heart disease and elevated periosteal pain sensitivity of the chest bone indicative of autonomic nervous system dysfunction, we test the hypotheses, (i) there is an association between the tilt table responses for the baroreflex-mediated cardiovascular response heart rate variability and periosteal pain sensitivity of the chest bone, (ii) these responses are affected differently by use of beta blockade medication, and (iii) reduction of an elevated periosteal pain sensitivity of the chest bone, during three months of non-pharmacological intervention, improves these responses to tilt table testing. Results: Baroreflex-mediated cardiovascular response, heart rate variability and periosteal pain sensitivity measures all changed significantly in response to tilt table test but only periosteal pain sensitivity and baroreflex-mediated cardiovascular responses were internally associated. Use of beta blockade medication inhibited the baroreflex-mediated cardiovascular response and heart rate variability responses but did not of periosteal pain sensitivity. In response to three months intervention with the aim to reduce the elevated periosteal pressure pain, all responses to tilt table test improved, but for the baroreflex-mediated cardiovascular response and heart variability in non-users of beta blockade, only. Participants who achieved a predefined minimum reduction of 15 units in periosteal pain sensitivity demonstrated significant improvement when compared to participants did not obtain this reduction. Conclusion: Periosteal pressure sensitivity of the chest bone at rest as well as the response to tilt table test seem new and promising measures of autonomic nervous system dysfunction, which remains unaffected by BB medication.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.